PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Carcinoma 433,099 Disease Target CA 72-4 184 66 0.01 -0.80 0.36 0.60
Carcinoma 433,099 Disease Target AFP 9,751 3,499 0.05 -0.80 0.36 0.66
BAFF 1,240 Target Target BLyS 457 164 0.22 -0.75 0.36 0.86
Collagenase-3 367 Target Target Collagen 138,882 132 0.02 -0.80 0.36 0.64
Collagen 138,882 Target Target Collagenase 3 367 132 0.02 -0.80 0.36 0.64
Carcinoma 433,099 Disease Target Carbonic Anhydrase 9 150 54 0.01 -0.80 0.36 0.60
Collagen 138,882 Target Target CD-RAP 44 16 0.01 -0.80 0.36 0.62
Cancer 1,053,491 Disease Target Multidrug Resistance Protein 1 495 183 0.01 -0.79 0.37 0.59
Obesity 138,233 Disease Target Melanin-Concentrating Hormone Receptor 1 143 53 0.01 -0.79 0.37 0.63
Cancer 1,053,491 Disease Target Aurora A kinase 318 118 0.01 -0.79 0.37 0.58
CCL2 3,560 Target Target CCL3 1,427 533 0.24 -0.73 0.37 0.85
CCL4 5,638 Target Target CCL3 1,427 535 0.19 -0.75 0.37 0.83
Androgen Receptor 12,918 Target Target Aldo-Keto Reductase Family 1 Member C3 8 3 0.01 -0.79 0.38 0.66
CD4 112,219 Target Target Exodus-3 8 3 0.00 -0.79 0.38 0.61
Cancer 1,053,491 Disease Target CHK2 1,391 533 0.01 -0.79 0.38 0.60
CHK2 1,391 Target Target CHK1 2,044 533 0.32 -0.68 0.38 0.89
Nephropathy Diabetic 13 Disease Target Renin 43,456 5 0.01 -0.78 0.38 0.64
Cancer 1,053,491 Disease Target Insulin-Like Growth Factor 1 Receptor 1,052 405 0.01 -0.78 0.38 0.59
Acute Promyelocytic Leukemia 4,780 Disease Target Retinoic Acid Receptor Alpha 1,068 413 0.18 -0.75 0.39 0.82
Inflammation 252,734 Disease Target CXCL2 750 291 0.02 -0.78 0.39 0.64
ERBB4 994 Target Target ERBB3 1,154 394 0.37 -0.63 0.40 0.91
Cancer 1,053,491 Disease Target AKT3 293 117 0.01 -0.77 0.40 0.58
Erbb2 4,536 Target Target Prostaglandin E2 Receptor Ep4 Subtype 5 2 0.01 -0.77 0.40 0.69
Dihydropteroate Synthase 408 Target Target Dihydrofolate Reductase 5,563 166 0.11 -0.76 0.41 0.78
CCL18 256 Target Target DC-CK1 22 9 0.12 -0.76 0.41 0.82
Cancer 1,053,491 Disease Target ERBB3 1,154 481 0.01 -0.76 0.42 0.60
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
Angiotensin-Converting Enzyme 2 665 Target Target Renin 43,456 283 0.05 -0.76 0.43 0.70
Carcinoma 433,099 Disease Target CXCL14/BRAK 7 3 0.00 -0.76 0.43 0.58
AMY2B 21 Target Target Alpha-Amylase 7,171 9 0.02 -0.76 0.43 0.70
Calmodulin 25,240 Target Target CAMK2B 21 9 0.01 -0.76 0.43 0.66
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Antithrombin 13,773 7 0.01 -0.75 0.44 0.67
Anxiety 113,510 Disease Target Neuropeptide S Receptor 77 34 0.01 -0.75 0.44 0.63
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
CCL5 2,002 Target Target CXCL4/PF4 9 4 0.03 -0.74 0.44 0.72
CXCL10/IP-10 114 Target Target CXCL4/PF4 9 4 0.12 -0.73 0.44 0.83
Cancer 1,053,491 Disease Target EPHA2 532 239 0.01 -0.74 0.45 0.59
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
Schizophrenia 77,034 Disease Target Metabotropic Glutamate Receptor 3 55 25 0.01 -0.74 0.45 0.64
Diabetes 332,602 Disease Target Exendin-4 855 392 0.02 -0.74 0.46 0.63
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Erbb2 4,536 Target Target ERBB4 994 461 0.22 -0.69 0.46 0.83
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
Cancer 1,053,491 Disease Target BRAF 4,766 2,231 0.03 -0.73 0.47 0.62
CEA 17,022 Target Target CA 15-3 898 437 0.11 -0.71 0.49 0.76
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
Cancer 1,053,491 Disease Target Adp/Atp Translocase 3 2 1 0.00 -0.71 0.50 0.56
Prostate Cancer 71,064 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 4 0.01 -0.71 0.50 0.63